Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate
Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate
Arcturus Therapeutics第一季度每股收益美元（1.00美元）超過預期（1.19美元），銷售額3,801萬美元超過預期的1754萬美元
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.19) by 15.97 percent. This is a 153.48 percent decrease over earnings of $1.87 per share from the same period last year. The company reported quarterly sales of $38.01 million which beat the analyst consensus estimate of $17.54 million by 116.72 percent. This is a 52.65 percent decrease over sales of $80.28 million the same period last year.
Arcturus Therapeutics（納斯達克股票代碼：ARCT）公佈的季度虧損爲每股1.00美元，比分析師共識估計的美元（1.19美元）高出15.97％。與去年同期的每股收益1.87美元相比，下降了153.48％。該公司公佈的季度銷售額爲3,801萬美元，比分析師普遍預期的1754萬美元高出116.72％。這比去年同期的8,028萬美元的銷售額下降了52.65％。